{"id":"NCT04228445","sponsor":"Prove pharm","briefTitle":"3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution as an Aid for Ureteral Patency","officialTitle":"An Open-Label Study of Two Different Doses of 3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution When Used as an Aid for Ureteral Patency","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-02-13","primaryCompletion":"2021-06-03","completion":"2021-06-03","firstPosted":"2020-01-14","resultsPosted":"2022-11-30","lastUpdate":"2022-11-30"},"enrollment":121,"design":{"allocation":"RANDOMIZED","model":"SEQUENTIAL","masking":"QUADRUPLE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Ureter Injury"],"interventions":[{"type":"DRUG","name":"3,3'-Dioxo-2,2'-bisindolylidene-5,5'-disulfonate disodium 0.8%","otherNames":[]},{"type":"DRUG","name":"Saline spray","otherNames":[]}],"arms":[{"label":"HIGH DOSE","type":"EXPERIMENTAL"},{"label":"LOW DOSE","type":"EXPERIMENTAL"},{"label":"Saline","type":"PLACEBO_COMPARATOR"}],"summary":"To determine whether the use of 3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution for injection provides a visualization advantage compared to saline when used as an aid in the determination of ureteral patency","primaryOutcome":{"measure":"Urine Jet Conspicuity Score","timeFrame":"10 minutes","effectByArm":[{"arm":"HIGH DOSE","deltaMin":4.1,"sd":1.34},{"arm":"LOW DOSE","deltaMin":4.2,"sd":1.17},{"arm":"Saline","deltaMin":2.5,"sd":1.1}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":9},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":60},"commonTop":["Constipation","Dysuria","Abdominal pain","Nausea","Pyrexia"]}}